Our videos for the Hall Hunter Partnership are helping to bring their new website alive.

Just take a look at their stunning new web design by clicking here

From humble beginnings, when were were asked to produce a simple short film, highlighting the work of one of Britain’s leading soft fruit growers, who supply most of the UK’s leading supermarkets, including Waitrose, Marks & Spencer and Sainsbury’s…we are now partnering with them on everything from recruitment videos to supermarket presentations.

Open Farm Sunday is another area where we have helped their business to promote their role in the local community and recently, during the Covid-19 pandemic, we featured some of the new UK pickers who had joined the business while on the furlough scheme.

Hall Hunter is a family owned business and has a much respected role in their local communities, working alongside schools and charities to ensure that they operate a sustainable corporate social responsibility programme in the areas where their farms are situated and beyond.

Professor Paul McGreevy shortly after receiving his medal at the University of Sydney

Congratulations to Professor Paul McGreevy who is the Australian winner of a 2020 World Veterinary Association Animal Welfare Award, supported by our clients, Ceva Animal Health.

We filmed Paul at his beautiful Hunter Valley home in New South Wales, Australia, for this year’s awards. The filming was completed before the Covid-19 lockdowns were introduced and this Autumn we put together a dynamic online awards ceremony which highlighted all the winners of the 2020 Awards.

Paul is one of Australia’s leading veterinarians and advises many different groups including the Royal Society for the Prevention of Cruelty to Animals (Australia). He has been working with the group on the use of the whip in Australian horse racing. Horses are close to Paul’s heart and during our visit to the Hunter Valley we were able to film him with several of his own horses and use our drone camera to capture him on horseback in his own dressage arena which is on his homestead plot.

Here’s the film we made in Australia:

We helped our client Volition RX, a multi-national epigenetics company developing simple, easy to use, cost effective blood tests to help diagnose a range of cancers and other diseases in both humans and animals, to stage their Capital Markets Day by generating a dynamic video presentation.

To see the video, click here

Volition CEO, Cameron Reynolds at the Wall Street Stock Exchange

The presentation focused on new data and the launch and commercial roll out of the company’s first product, the Nu.Q™ Vet Cancer Screening Test, which is on target for a launch this year. The presentation also provided an update on recent developments and Volition’s activities, including new and ongoing clinical trials in blood cancer.

Commenting on the event Cameron Reynolds, President and Chief Executive Officer of Volition said, “We were delighted to host a busy virtual capital markets event yesterday and would like to thank all of those that joined the event live. This is an exciting time for the company as we prepare for the launch of the Nu.Q™ Vet Cancer Screening Test later this year. I am equally delighted to share a video of the presentation and Analyst Question and Answer session so that those unable to attend can view in their own time.”

We have been partnering with Volition for several years and work with them to produce their regular financial results.

As our client Volition RX, listed on the New York Stock exchange, gets closer to producing a simple blood test for cancer keeping investors abreast of key developments has been vital.   Good Call Media’s studio has ensured that we could keep producing our regular financial quarterly bulletins but we have also been busy with other regular news
updates.

For example Volition presented three abstracts at the American Society of Clinical Oncology (ASCO) 2020 annual meeting with three films produced to accompany each
paper.  

To see one of the films  a short video produced to accompany the lung cancer abstract click here:

And with a growing German investor audience all our quarterly results films can now be seen with German subtitles. 

Second Quarter 2020 Results and Business Update from Volition on Vimeo.

Our client Volition RX may soon be helping in the fight against the Covid-19 pandemic.

Excitingly Volition have discovered that the patented technology behind their cancer tests may well also be used to develop a COVID-19 Triage test.  It is hoped that this test will tell doctors if a patient with Covid is likely to go on and develop serious symptoms or complications.  Further trials are continuing with the aim of producing a CE-marked product for this by the end of 2020. 

We have been helping them update their investors and the world at large about the possible breakthrough.

Commenting on the results, corresponding author Professor Stefan Holdenrieder, Director of the Institute of Laboratory Medicine, German Heart Center, Munich, Germany said, “We tested two independent cohorts of COVID-19 positive patients with quantitative nucleosome immunoassays and found that nucleosomes were highly elevated in plasma of severe COVID-19 patients relative to healthy control subjects and that both histone 3.1 variant and citrullinated nucleosomes increased with disease severity. Given that the highest levels of nucleosomes were found in patients requiring artificial ventilation or extracorporeal oxygenation, we believe that nucleosomes could serve as a guiding biomarker for disease severity in COVID-19 positive patients.”

Cameron Reynolds, Chief Executive Officer of Volition commented, “Nu.QTM has shown correlation with more severe COVID-19 cases implying strong prognostic potential, and we are now focused on the completion of larger longitudinal studies that would be needed to support a potential COVID-19 product launch. If we continue to see positive results in these longitudinal studies, we aim to have a CE-marked product available on multiple platforms in 2020 and will look to launch a low-cost product that could be used in any laboratory worldwide as soon as possible thereafter.”

To read more about it and see our film click here.